500 related articles for article (PubMed ID: 35294540)
21. Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected Hispanics living in the United States.
Ortiz AP; Engels EA; Nogueras-González GM; Colón-López V; Soto-Salgado M; Vargas A; Machin M; Shiels MS
Cancer; 2018 Dec; 124(23):4520-4528. PubMed ID: 30345506
[TBL] [Abstract][Full Text] [Related]
22. Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management.
Mix J; Saraiya M; Hallowell BD; Befano B; Cheung LC; Unger ER; Gargano JW; Markowitz LE; Castle PE; Raine-Bennett T; Walker J; Zuna R; Schiffman M; Wentzensen N; Gage JC
J Natl Cancer Inst; 2022 Jun; 114(6):845-853. PubMed ID: 35176161
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus-associated cancers - United States, 2004-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Apr; 61():258-61. PubMed ID: 22513527
[TBL] [Abstract][Full Text] [Related]
24. Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway.
Hansen BT; Campbell S; Nygård M
BMJ Open; 2018 Feb; 8(2):e019005. PubMed ID: 29476028
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Nov; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
[TBL] [Abstract][Full Text] [Related]
26. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.
Arbyn M; de Sanjosé S; Saraiya M; Sideri M; Palefsky J; Lacey C; Gillison M; Bruni L; Ronco G; Wentzensen N; Brotherton J; Qiao YL; Denny L; Bornstein J; Abramowitz L; Giuliano A; Tommasino M; Monsonego J
Int J Cancer; 2012 Nov; 131(9):1969-82. PubMed ID: 22623137
[TBL] [Abstract][Full Text] [Related]
27. Racial and Ethnic Variation Associated With Human Papillomavirus Genotype in Anal Dysplasia.
Mather TL; Hu KY; Rein LE; Szabo A; Lundeen SJ; Peterson CY; Ludwig KA; Ridolfi TJ
J Surg Res; 2020 Dec; 256():311-316. PubMed ID: 32712446
[TBL] [Abstract][Full Text] [Related]
28. Trends in Human Papillomavirus-Associated Cancers - United States, 1999-2015.
Van Dyne EA; Henley SJ; Saraiya M; Thomas CC; Markowitz LE; Benard VB
MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):918-924. PubMed ID: 30138307
[TBL] [Abstract][Full Text] [Related]
29. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
[TBL] [Abstract][Full Text] [Related]
31. Human Papillomavirus Awareness by Educational Level and by Race and Ethnicity.
Stephens ES; Dema E; McGee-Avila JK; Shiels MS; Kreimer AR; Shing JZ
JAMA Netw Open; 2023 Nov; 6(11):e2343325. PubMed ID: 37962885
[TBL] [Abstract][Full Text] [Related]
32. Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.
Bogaards JA; Wallinga J; Brakenhoff RH; Meijer CJ; Berkhof J
BMJ; 2015 May; 350():h2016. PubMed ID: 25985328
[TBL] [Abstract][Full Text] [Related]
33. Should men be exempted from vaccination against human papillomavirus? Health disparities regarding HPV: the example of sexual minorities in Poland.
Reszka K; Moskal Ł; Remiorz A; Walas A; Szewczyk K; Staszek-Szewczyk U
J Prev Med Hyg; 2021 Jun; 62(2):E386-E391. PubMed ID: 34604578
[TBL] [Abstract][Full Text] [Related]
34. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.
Gillison ML; Chaturvedi AK; Lowy DR
Cancer; 2008 Nov; 113(10 Suppl):3036-46. PubMed ID: 18980286
[TBL] [Abstract][Full Text] [Related]
35. Epidemiological dynamic modeling of human papillomavirus-related diseases to assess vaccination strategies in Argentina.
Borracci RA; Segal SV; Méndez JH
Medicina (B Aires); 2018; 78(5):315-328. PubMed ID: 30285924
[TBL] [Abstract][Full Text] [Related]
36. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
Medeiros R; Vaz S; Rebelo T; Figueiredo-Dias M
Acta Med Port; 2020 Mar; 33(3):198-201. PubMed ID: 32130098
[TBL] [Abstract][Full Text] [Related]
37. Understanding the burden of human papillomavirus-associated anal cancers in the US.
Joseph DA; Miller JW; Wu X; Chen VW; Morris CR; Goodman MT; Villalon-Gomez JM; Williams MA; Cress RD
Cancer; 2008 Nov; 113(10 Suppl):2892-900. PubMed ID: 18980293
[TBL] [Abstract][Full Text] [Related]
38. [Human Papillomavirus: screening of cervical and anal cancers].
Pache B; Jacot-Guillarmod M; Hübner M; Mathevet P
Rev Med Suisse; 2022 Oct; 18(800):1950-1955. PubMed ID: 36259700
[TBL] [Abstract][Full Text] [Related]
39. Incidence, Trends and Ethnic Differences of Oropharyngeal, Anal and Cervical Cancers: Singapore, 1968-2012.
Lam JO; Lim WY; Chow KY; D'Souza G
PLoS One; 2015; 10(12):e0146185. PubMed ID: 26720001
[TBL] [Abstract][Full Text] [Related]
40. Human Papillomavirus Vaccine Administration Trends Among Commercially Insured US Adults Aged 27-45 Years Before and After Advisory Committee on Immunization Practices Recommendation Change, 2007-2020.
Suk R; Liao K; Bauer CX; Basil C; Li M
JAMA Health Forum; 2022 Dec; 3(12):e224716. PubMed ID: 36525257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
